GlassScriptPhysician profile
Mitchell Creinin
NPI 1801868484
$199,970.85
in general payments reported to CMS, 2019-2025
14 companies · $8,504 in 2025
The $8,504 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,583 · 2020: $19K · 2021: $24K · 2022: $36K · 2023: $55K · 2024: $49K · 2025: $8,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $69K · Honoraria: $27K · Travel and Lodging: $9,162 · Consulting Fee: $5,074 · Food and Beverage: $2,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $69,040.00 |
| Honoraria | $26,650.00 |
| Travel and Lodging | $9,162.31 |
| Consulting Fee | $5,073.75 |
| Food and Beverage | $2,606.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $136,551.46 | 2019-2025 | |
| Organon LLC | $26,237.25 | 2022-2024 | |
| Medicines360 | $15,619.95 | 2019-2025 | Liletta |
| Merck Sharp & Dohme LLC | $12,403.75 | 2019-2025 | |
| Viiv Healthcare Company | $5,200.00 | 2022 | |
| Abbvie INC. | $2,621.86 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,214.72 | 2025 | |
| Amag Pharmaceuticals, INC. | $121.86 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Creinin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.